ArticleVirchows Archiv : an international journal of pathology2026
HPV in oropharyngeal squamous papillomas: a missing link in head and neck viral pathogenesis.
Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The role of human papillomaviruses (HPV) in oropharyngeal squamous papillomas remains incompletely defined, in contrast to their established involvement in oropharyngeal squamous cell carcinoma and laryngeal papillomatosis. This study aimed to assess HPV prevalence, genotype distribution, and associated biomarker expression in oropharyngeal papillomas, with particular emphasis on p16 and viral E4 protein immunoexpression. We retrospectively analyzed 51 formalin-fixed paraffin-embedded oropharyngeal squamous papillomas diagnosed between 2015 and 2023. HPV DNA detection and genotyping were performed using the INNO-LiPA assay. Immunohistochemistry for p16 and E4 was correlated with HPV status. For comparison, 20 oropharyngeal squamous cell carcinomas were included as controls, comprising 10 HPV16-positive and 10 HPV-negative cases. HPV DNA was detected in 57% of papillomas, predominantly high-risk genotypes, most frequently HPV16. E4 immunoexpression was observed in 55.5% of evaluable cases and was significantly associated with HPV DNA positivity (p < 0.0001). In contrast diffuse p16 overexpression was uncommon and showed no significant association with HPV detection. The prevailing immunophenotype in HPV-positive papillomas was E4 + /p16-, whereas HPV16-positive carcinomas uniformly exhibited a p16 + /E4- profile. No statistically significant differences in recurrence, dysplasia, or malignant transformation were observed between HPV-positive and HPV-negative papillomas, although adverse events occurred exclusively in high-risk HPV-associated cases. These findings suggest that a substantial subset of oropharyngeal squamous papillomas is associated with productive high-risk HPV infection, biologically distinct from transforming infections seen in carcinoma. While combined E4/p16 immunoprofiling may contributed to lesion characterization and prognostic stratification, its clinical utility warrants validation in larger, prospective cohorts.
Indexed as
Identifiers
41957321What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.